1. Desmoglein 1 deficiency results in severe dermatitis, multiple allergies and metabolic wasting
- Author
-
Reuven Bergman, Ofer Isakov, Akemi Ishida-Yamamoto, Christabelle S M Goh, Andrea Gat, Neil J. Wilson, Michael A. Simpson, Ofer Sarig, Liat Samuelov, Jennifer L. Koetsier, Noam Shomron, Eli Sprecher, W.H. Irwin McLean, Mia Horowitz, Alan D. Irvine, Robert M. Harmon, Sarit Peleg, Debora Rapaport, Kathleen J. Green, John A. McGrath, O. Eytan, Frances J.D. Smith, Ronen Spiegel, Elizabeth Pohler, Shamir Geller, and Ilan Goldberg
- Subjects
Male ,Allergy ,Dermatitis ,Biology ,medicine.disease_cause ,Severity of Illness Index ,Article ,Pathogenesis ,Hypersensitivity ,Genetics ,medicine ,Humans ,Netherton syndrome ,Wasting Syndrome ,Child ,Wasting ,Barrier function ,Mutation ,integumentary system ,Desmoglein 1 ,Infant ,Syndrome ,medicine.disease ,Child, Preschool ,Immunology ,Female ,medicine.symptom - Abstract
The relative contribution of immunological dysregulation and impaired epithelial barrier function to allergic diseases is still a matter of debate. Here we describe a new syndrome featuring severe dermatitis, multiple allergies and metabolic wasting (SAM syndrome) caused by homozygous mutations in DSG1. DSG1 encodes desmoglein 1, a major constituent of desmosomes, which connect the cell surface to the keratin cytoskeleton and play a crucial role in maintaining epidermal integrity and barrier function. SAM syndrome-causing mutations resulted in lack of membrane expression of DSG1, leading to loss of cell-cell adhesion. In addition, DSG1 deficiency was associated with increased expression of a number of genes encoding allergy-related cytokines. The deciphering of the pathogenesis of SAM syndrome substantiates the notion that allergy may result from a primary structural epidermal defect.
- Published
- 2013